US PTAB Patent Cases
8,722 decisions indexed
Page 257 of 291 · 8,722 total
Datavant, Inc. et al. v.Vigilytics LLC
Datavant, Inc. challenges Vigilytics LLC's patent (9665685) in an IPR proceeding over de-identification and tokenization methods for healthcare data. The petitioner asserts that the claimed method is obvious based on combinations of prior art references like Evenhaim, Settimi, Dick, Landi, and Murphy.
Datavant, Inc. et al. v.Vigilytics LLC
Datavant successfully challenged the validity of Vigilytics' patent 9665685 in an IPR proceeding. The PTAB found a reasonable likelihood of success on all grounds, instituting the case for further review.
Datavant, Inc. et al. v.Vigilytics LLC
Datavant, Inc. successfully challenged 20 claims of Vigilytics LLC's patent (10886012) in an IPR proceeding, arguing that the technology for de-identifying medical data was obvious over prior art references like Evenhaim and Murphy. The PTAB decided to institute the case, finding a reasonable likelihood Petitioner would prevail on at least one claim.
US Conec Ltd. v.Senko Advanced Components, Inc.
The PTAB denied US Conec's request to institute IPR against Senko Advanced Components, finding that the Petitioner failed to show a reasonable likelihood of prevailing on any challenged claims related to fiber optic connectors.
US Conec Ltd. v.Senko Advanced Components, Inc.
Petitioner US Conec Ltd. challenges U.S. Patent No. 11,061,190 by asserting obviousness (Section 103) over multiple combinations of prior art references including Nakagawa, Raven, Veatch, Connelly, and Cline. The petitioner argues that the combination of these references would have been predictable to a POSITA, while also contesting the applicability of § 325(d) discretionary denial.
Cisco Systems, Inc. v.Portsmouth Network Corporation
Cisco Systems challenges Portsmouth Network Corporation's patent (8014394) in a PTAB Petition, arguing that the claims are obvious under 35 U.S.C. § 103. The petitioner asserts that combining various prior art references renders nearly all challenged claims unpatentable.
Cisco Systems, Inc. v.Portsmouth Network Corporation
Cisco Systems successfully petitioned to challenge Portsmouth Network Corporation's patent (8014394) in an IPR proceeding, leading the PTAB to institute the case. The Board found a reasonable likelihood of prevailing for several claims based on obviousness over prior art references Weyman and Li.
Cisco Systems, Inc. v.Portsmouth Network Corporation
The PTAB found the patent claims unpatentable under 35 U.S.C. § 103(a) based on various combinations of prior art references. The Petitioner successfully demonstrated that combining existing network technologies taught or rendered obvious the claimed limitations, particularly in multicast routing and packet processing.
TESLA, INC. v.Autonomous Devices, LLC
Tesla’s IPR against Autonomous Devices’ ’974 patent resulted in the Board finding claims 4 and 11 unpatentable and also striking the proposed substitute claims 21 and 24‑26, while leaving claims 5, 7 and other substitutes intact.
Toyota Motor Corporation et al. v.Infogation Corp.
Toyota and Infogation settled their IPR dispute over patent 6,292,743 B1, leading the Board to dismiss the case before a trial. The settlement agreement is treated as confidential under statutory provisions.
Toyota Motor Corporation et al. v.Infogation Corp.
Toyota filed a joint motion to dismiss the IPR (2024-00756) against Infogation’s patent 6,292,743.
Toyota Motor Corporation et al. v.Infogation Corp.
Toyota Motor Corp and Infogation Corp settled their inter partes review dispute before any trial, leading the PTAB to dismiss the proceedings and keep the settlement confidential.
Disney Media and Entertainment Distribution, LLC v.Digital Media Technology Holdings, LLC
Disney challenges the PTAB’s finding of unpatentability for a movie‑distribution method, arguing the Board relied on an improper combination of prior art. The petition seeks Director review of the decision.
Toyota Motor Corporation et al. v.Infogation Corp.
Toyota Motor Corp. and Infogation Corp. have settled their dispute over U.S. Patent 10,107,628 and jointly moved to dismiss the pending IPR. The Board has not yet instituted the review, and the parties argue dismissal is appropriate at this early stage.
Cala Health, Inc. v.EMKinetics, Inc.
The Board issued an order granting Cala Health and EMKinetics' joint request to keep their Confidential Settlement Agreement private under 37 C.F.R. §42.74(c). The agreement will be treated as business confidential information and kept separate from the patent file.
Cala Health, Inc. v.EMKinetics, Inc.
The PTAB issued an order in IPR2024‑00732 and IPR2024‑00743 requiring Cala Health and EMKinetics to file a true copy of their settlement agreement before the proceedings can be terminated.
Cala Health, Inc. v.EMKinetics, Inc.
Cala Health and EMKinetics jointly moved to dismiss IPR2024‑00743 covering claims 1‑17 of U.S. Patent 11,628,300. The parties cite a confidential settlement and the early, pre‑institution stage of the proceeding as reasons for dismissal.
Disney Media and Entertainment Distribution, LLC v.Digital Media Technology Holdings, LLC
Disney challenges the Patent Owner’s request for Director Review, asserting that the Board’s claim constructions and prior‑art analysis were correct. The response contends the request adds no new arguments and should be denied.
Disney Media and Entertainment Distribution, LLC v.Digital Media Technology Holdings, LLC
Digital Media Technology Holdings seeks a 30‑day extension to file a Director Review request after the PTAB’s final decision on its U.S. Patent 7,574,725, citing good cause due to counsel’s age and heavy workload.
Cala Health, Inc. v.EMKinetics, Inc.
Cala Health and EMKinetics filed a joint request asking the PTAB to keep their settlement agreement confidential under 35 U.S.C. §317, citing competitive harm if disclosed. The Board has yet to rule on the request.
Cala Health, Inc. v.EMKinetics, Inc.
The PTAB issued an order granting Cala Health and EMKinetics' joint request to keep their settlement agreement confidential under 37 C.F.R. §42.74(c), separating it from the IPR file.
Cala Health, Inc. v.EMKinetics, Inc.
The PTAB issued an order compelling Cala Health and EMKinetics to file a true copy of their settlement agreement before the joint motion to dismiss can be acted upon, emphasizing compliance with 37 C.F.R. § 42.74(b). A dissenting judge argues the rule does not apply pre‑institution.
Aylo Freesites Ltd et al. v.WellcomeMat, LLC
WellcomeMat seeks Director Review of a Board decision that declared its video‑editing cue‑point patent invalid. The Owner contends the Board misapplied legal standards on anticipation, obviousness, and claim construction.
Aylo Freesites Ltd et al. v.WellcomeMat, LLC
The PTAB granted institution of an IPR against WellcomeMat’s 8,307,286 patent covering video cue‑point processing for online real‑estate videos. Petitioner Aylo Freesites showed a reasonable likelihood of success on at least one claim, and the Board rejected discretionary denial arguments.
Aylo Freesites Ltd et al. v.WellcomeMat, LLC
Aylo Freesites Ltd responded to WellcomeMat’s Director Review request, arguing the Board correctly found claims 13‑15 and 17‑20 of the ’286 patent unpatentable based on proper prior‑art comparison. The Board’s analysis of the video‑editing environment claim term was upheld, and the request for review should be denied.
Aylo Freesites Ltd et al. v.WellcomeMat, LLC
The USPTO denied Aylo Freesites’ request for Director Review of the Final Written Decision in IPR2024-00710, leaving the patent owner’s rights intact.
Motorola Mobility LLC v.Largan Precision Co., Ltd.
Motorola Mobility seeks Director Review of the PTAB’s denial to institute an IPR against Largan’s 9,997,660 patent covering a light‑trap optical sheet. The petitioner claims the Board erred by dismissing simultaneous‑invention evidence and applying an unduly rigid obviousness test.
Cala Health, Inc. v.EMKinetics, Inc.
Cala Health and EMKINETICS settled their dispute over two patents, filing a joint motion that led the PTAB to terminate the inter partes review proceedings before trial.
Cala Health, Inc. v.EMKinetics, Inc.
Cala Health and EMKinetics settled their dispute over two patents, filing a joint motion that led the PTAB to terminate the IPRs before any trial was instituted.
Cala Health, Inc. v.EMKinetics, Inc.
Cala Health and EMKinetics filed a joint motion to dismiss the IPR over U.S. Patent 10,786,669, citing a confidential settlement and the early stage of the proceeding. They request the Board terminate the case before institution to preserve resources.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.